Neos Therapeutics, Inc. NEOS
No live quote for NEOS yet.
P/E -4.4×
P/S 1.2×
P/B -12.2×
P/FCF -6.3×
EV/EBITDA -22.0×
EV/Sales 1.6×
FCF Yield -15.9%
Gross Margin 61.1%
Operating Margin -16.1%
Net Margin -26.1%
ROE 275.7%
ROIC -24.0%
ROA -18.6%
Revenue 29.3%
Operating Income 76.1%
EPS (diluted) 78.8%
Free Cash Flow 72.1%
Current Ratio 1.1×
Quick Ratio 0.9×
Debt / Equity -7.3×
Net Debt / EBITDA -6.0×
Interest Coverage -1.3×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2019-12-31